NDAORALTABLET
Approved
Nov 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 14h ago · AI intelligence enriched 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IMODIUM MULTI-SYMPTOM RELIEF is an oral tablet combining loperamide hydrochloride (an antidiarrheal agent) and dimethicone (an anti-gas agent) for over-the-counter treatment of diarrhea with bloating and gas. The combination targets both primary gastrointestinal symptoms to provide symptomatic relief in acute gastroenteritis and functional diarrhea.
LOE Approaching
This OTC product is in the late maturity phase with moderate competitive pressure (30/100), suggesting focused brand defense efforts rather than growth investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on IMODIUM MULTI-SYMPTOM positions professionals in established OTC brand management with emphasis on market defense, retailer relationships, and consumer loyalty rather than innovation or clinical advancement. Career trajectory depends on ability to manage decline, drive line extensions, or support parent company portfolio optimization in the Kenvue portfolio.
Brand Manager
Worked on IMODIUM MULTI-SYMPTOM RELIEF at Kenvue Brands? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.